Questions About Cancer? 1-800-4-CANCER

Childhood Soft Tissue Sarcoma Treatment (PDQ®)

Health Professional Version

Changes to This Summary (12/17/2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment of Progressive/Recurrent Childhood Soft Tissue Sarcoma

Added text to state that published results of two studies addressed the outcomes for children with relapsed synovial sarcoma; most patients in one study had distant relapse, while most patients in the second study had local relapse. Distant recurrence was a poor prognostic variable, while tumor resectability at relapse was associated with a better outcome in both studies (cited Ferrari et al. and Soole et al. as references 10 and 11, respectively).

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  • Updated: December 17, 2014